Stryker Corp
NYSE:SYK

  • LAST PRICE
    336.5000
  • TODAY'S CHANGE (%)
    -2.3700 (-0.6994%)
  • Bid / Lots
    324.9500/ 1
  • Ask / Lots
    338.9400/ 3
  • Open / Previous Close
    337.6500 / 338.8700
  • Day Range
    336.3200
    340.4100
  • 52 Week Range
    249.9800
    361.4100
  • Volume
    2,480,636

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 4 hours ago by MT Newswires
      Companies Mentioned: SYK
      04:43 PM EDT, 04/30/2024 (MT Newswires) -- Stryker (SYK) reported Q1 adjusted earnings late Tuesday of $2.50 per diluted share, up from $2.14 a year earlier. Analysts polled by Capital IQ expected $2.36. Net sales in the quarter ended March 31 rose ...

    • 4 hours ago by MT Newswires
      Companies Mentioned: SYK
      04:23 PM EDT, 04/30/2024 (MT Newswires) -- Price: 330.00, Change: -6.34, Percent Change: -1.88 ...

    • 4 hours ago by MT Newswires
      Companies Mentioned: SYK
      04:20 PM EDT, 04/30/2024 (MT Newswires) -- ...

    • 4 hours ago by Dow Jones
      Companies Mentioned: SYK

      By Ben Glickman

      Stryker raised its full-year forecast for organic sales growth after its first-quarter profit and revenue both rose more than expected.

      The Portage, Mich.-based medical technology company reported a profit of $788 million, or $2.05 a share, in the quarter ended March 31, compared with a profit of $592 million, or $1.54 a share, a year earlier. Analysts polled by FactSet expected a per-share profit of $1.99.

    • 4 hours ago by Dow Jones
      Companies Mentioned: SYK
      Recall-related matters (d) -- (5) -- 5 -- 1 4 0.1 0.01 Regulatory and legal matters (e) -- (2) -- 2 -- 1 1 -- -- Tax matters (f) -- -- -- -- -- (41) 41 (4.4) 0.11 ------------- ------------- ----- ------------ ----- ------------- ------------- ------------ ------------ ------------ ------------ Adjusted $ 3,337 $ 1,835 $ 356 $ 1,146 $ (49) $ 135 $ 962 12.3% $ 2.50 ------------- ------------- ----- ------------ ----- ------------- ------------- ------------ ------------ ------------ ------------ Adjusted percent net sales 63.6% 35.0% 6.8% 21.9% (0.9) % nm 18.3% ============= ============= ==== ============ ==== ============= ================= ============= ============ Research, Selling, General & Development & Administrative Engineering Other Income Income Effective Three Months 2023 Gross Profit Expenses Expenses Operating Income (Expense), Net Taxes Net Earnings Tax Rate Diluted EPS ----------------------- ------------------ --------------------- -------------------- ------------------ ----------------- ----------- ----------------- ----------------- ------------- Reported $ 3,016 $ 1,781 $ 339 $ 735 $ (56) $ 87 $ 592 12.8% $ 1.54 Reported percent net sales 63.1% 37.3% 7.1% 15.4% (1.2) % nm 12.4% Acquisition and integration-related costs: Inventory stepped-up to fair value -- -- -- -- -- -- -- -- -- Other acquisition and integration-related (a) -- (6) -- 6 -- 1 5 0.1 0.01 Amortization of purchased intangible assets -- -- -- 161 -- 34 127 2.0 0.33 Structural optimization and other special charges (b) 2 (40) -- 42 -- 8 34 0.3 0.09 Medical device regulations (c) -- -- (28) 28 -- 5 23 0.2 0.06 Recall-related matters (d) -- -- -- -- -- -- -- -- -- Regulatory and legal matters (e) -- (34) -- 34 -- 6 28 0.3 0.07 Tax matters (f) -- -- -- -- (9) (20) 11 (2.9) 0.04 ------------- ------------- ----- ------------ ----- ------------- ------------- ---------- ------------ ------------- ------------ Adjusted $ 3,018 $ 1,701 $ 311 $ 1,006 $ (65) $ 121 $ 820 12.8% $ 2.14 ------------- ------------- ----- ------------ ----- ------------- ------------- ---------- ------------ ------------- ------------ Adjusted percent net sales 63.2% 35.6% 6.5% 21.1% (1.4) % nm 17.2% ============= ============= ==== ============ ==== ============= ================= =========== ============

Peers Headlines